ESCC clinical trials at UCLA

1 research study open to eligible people

First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors
open to eligible people ages 18 years and up
A Phase 1, First in Human, Open-Label Multicenter Study to Evaluate ALX2004, an Antibody Drug Conjugate Targeting EGFR in Participants with Advanced or Metastatic Select Solid Tumors
Santa Monica, California and other locations

Last updated: September 28, 2026